Cicloprolol

Drug Profile

Cicloprolol

Alternative Names: SL 75177; SL 75177 10; SLD 177

Latest Information Update: 14 May 1997

Price : $50

At a glance

  • Originator Sanofi-Synthelabo
  • Class
  • Mechanism of Action Beta 1 adrenergic receptor agonists; Beta 2 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Hypertension; Ischaemic heart disorders

Most Recent Events

  • 14 May 1997 Discontinued-preregistration for Heart failure in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top